Rosiglitazone Maleate

Rosiglitazone is used in the treatment of type 2 diabetes mellitus which is also known as non-insulin-dependent diabetes (NIDDM).

Rosiglitazone operates by reducing the amount of glucagon and increases the amount of insulin produced by the pancreas to control the blood sugar levels in the body. Glucagon causes the liver to produce more sugar, so by Rosiglitazone reducing the amount of glucagon in the body, this also helps to reduce the levels of glucose in the blood which then helps in the treatment of type 2 diabetes.

Patients who take Rosiglitazone may suffer from such side effects;

Hypoglycemia,
Hyperglycemia,
Severe nausea,
Changes to your menstrual cycle,
Changes to your urine colour,
Abdomen or stomach pain,
Jaundice,
Bone fractures,
Changes to your heartbeat or rate,
Changes to your vision,
lurred vision,
Respiratory tract infection,
Bone fracture,
Numbness